Dry-eye disease market forecast to expand at 4.5% CAGR

The incidence of dry-eye disease is increasing and so is the competition prevailing in the global dry eye disease market.

In a recent study, Transparency Market Research (TMR) has predicted positive trajectory for the market, during the course of which it is likely to witness heightened competition. With several market players standing on the brink of patent expiries, investment toward research and development of novel drugs will accelerate. With this, the market can expect increased enrollments in clinical trials.

Furthermore, market players are likely to forge strategic collaborations and ink licensing agreements to establish a stronger foothold in the global dry eye-disease market. During this time the market will also witness the leading companies backing their powerhouse drugs to cut off rivalry.